Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 13;7(10):180.
doi: 10.3390/children7100180.

How Do We Monitor Oxygenation during the Management of PPHN? Alveolar, Arterial, Mixed Venous Oxygen Tension or Peripheral Saturation?

Affiliations
Review

How Do We Monitor Oxygenation during the Management of PPHN? Alveolar, Arterial, Mixed Venous Oxygen Tension or Peripheral Saturation?

Praveen Chandrasekharan et al. Children (Basel). .

Abstract

Oxygen is a pulmonary vasodilator and plays an important role in mediating circulatory transition from fetal to postnatal period. Oxygen tension (PO2) in the alveolus (PAO2) and pulmonary artery (PaO2) are the main factors that influence hypoxic pulmonary vasoconstriction (HPV). Inability to achieve adequate pulmonary vasodilation at birth leads to persistent pulmonary hypertension of the newborn (PPHN). Supplemental oxygen therapy is the mainstay of PPHN management. However, optimal monitoring and targeting of oxygenation to achieve low pulmonary vascular resistance (PVR) and optimizing oxygen delivery to vital organs remains unknown. Noninvasive pulse oximetry measures peripheral saturations (SpO2) and a target range of 91-95% are recommended during acute PPHN management. However, for a given SpO2, there is wide variability in arterial PaO2, especially with variations in hemoglobin type (HbF or HbA due to transfusions), pH and body temperature. This review evaluates the role of alveolar, preductal, postductal, mixed venous PO2, and SpO2 in the management of PPHN. Translational and clinical studies suggest maintaining a PaO2 of 50-80 mmHg decreases PVR and augments pulmonary vasodilator management. Nevertheless, there are no randomized clinical trials evaluating outcomes in PPHN targeting SpO2 or PO2. Also, most critically ill patients have umbilical arterial catheters and postductal PaO2 may not be an accurate assessment of oxygen delivery to vital organs or factors influencing HPV. The mixed venous oxygen tension from umbilical venous catheter blood gas may assess pulmonary arterial PO2 and potentially predict HPV. It is crucial to conduct randomized controlled studies with different PO2/SpO2 target ranges for the management of PPHN and compare outcomes.

Keywords: PPHN; oxygen tension; oxygenation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The primary determinant of hypoxic pulmonary vasoconstriction is the precapillary pulmonary arteriole. The oxygen tension at this site is determined by alveolar PAO2 and pulmonary arterial PO2. In the absence of lung disease, pulmonary venous PO2 and alveolar PAO2 are usually similar. In the absence of significant shunts, preductal PaO2 is reflective of pulmonary venous PO2. Umbilical venous PO2 is similar to mixed venous PO2 and pulmonary arterial PO2 in the absence of a left-to-right atrial/ductal shunt. Oxygen delivery to the brain and heart is based on preductal PaO2 and SpO2. Postductal PaO2 (from an umbilical arterial line) can be low and does not predict PVR or oxygen delivery to vital organs. Copyright Satyan Lakshminrusimha.
Figure 2
Figure 2
Created using data from Custer et al. [31]. Importance of alveolar hypoxia in directing lung blood flow. Neonatal lambs and adult sheep were instrumented. Each lung was intubated with a different endotracheal tube. One lung was ventilated with 100% oxygen and the other test lung with varying concentrations of oxygen mixed with nitrogen. Relative distribution of perfusion was calculated with Qp1 (blood flow to test lung) and Qp2 (blood flow to the 100% oxygen lung) using the formula shown in the figure. Lower PAO2 had a profound effect on pulmonary vasoconstriction in newborn ovine model (red line) compared to adults (blue line).
Figure 3
Figure 3
A graph depicting the relationship of inspired oxygen, PVR, left pulmonary blood flow, arterial oxygenation and preductal SpO2 is illustrated in an ovine model of meconium aspiration model with PPHN. [36] The pulmonary vascular resistance (PVR—brown cross), pulmonary blood flow (Qp—purple open circles), FiO2 (blue circles) and PaO2 (red squares) at different preductal saturation (SpO2) ranges are shown. Preductal SpO2 in high 80 s resulted in high PVR and low Qp. Preductal SpO2 in the low−90 s was associated with increased PaO2, increased Qp, low FiO2 and high PVR (due to high pulmonary arterial pressure–not shown). Preductal SpO2 in the mid−90 s was associated with FiO2 in the 0.5 range with lowest PVR, highest Qp in this model. Increasing FiO2 to 1.0 increased PaO2 and SpO2 but did not result in further increase in Qp or decrease in PVR. For detailed statistical analysis, please refer to Rawat et al. [36]. Copyright Satyan Lakshminrusimha.
Figure 4
Figure 4
The scatterplot between PVR and PVO2 is shown in (A) meconium aspiration model and (B) preterm RDS model. The PVO2 was obtained from the main pulmonary artery blood gas. The MCMC model using SAS 9.4 (NC) estimated change point. Copyright MR/PC/SL.
Figure 5
Figure 5
The relation between SpO2 (y-axis) and PaO2 (x-axis) in hypothermia and normothermia is shown. In normothermia and hypothermia, the relationship between SpO2 and PaO2 is altered. Targeting a preductal corrected PaO2 of 50–80 mmHg may require preductal SpO2 in the mid- to high 90 s during management of severe PPHN on whole body hypothermia. Copyright Satyan Lakshminrusimha.

Similar articles

Cited by

References

    1. Abman S.H., Hansmann G., Archer S.L., Ivy D.D., Adatia I., Chung W.K., Hanna B.D., Rosenzweig E.B., Raj J.U., Cornfield D., et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015;132:2037–2099. doi: 10.1161/CIR.0000000000000329. - DOI - PubMed
    1. Evans N.J., Archer L.N. Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease. Arch. Dis. Child. 1991;66:6–11. doi: 10.1136/adc.66.1_Spec_No.6. - DOI - PMC - PubMed
    1. Halliday H., Hirschfeld S., Riggs T., Liebman J., Fanaroff A., Bormuth C. Respiratory distress syndrome: Echocardiographic assessment of cardiovascular function and pulmonary vascular resistance. Pediatrics. 1977;60:444–449. - PubMed
    1. Skinner J.R., Boys R.J., Hunter S., Hey E.N. Pulmonary and systemic arterial pressure in hyaline membrane disease. Arch. Dis. Child. 1992;67:366–373. doi: 10.1136/adc.67.4_Spec_No.366. - DOI - PMC - PubMed
    1. Walther F.J., Benders M.J., Leighton J.O. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics. 1992;90:899–904. - PubMed